FPAS
CRBU icon

Focus Partners Advisor Solutions’s Caribou Biosciences CRBU Stock Holding History

Focus Partners Advisor Solutions’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,216
Closed -$19.4K – 1272
2025
Q4 		$19.4K Sell
12,216
-35
-0.3% -$73 ﹤0.01% 1084
2025
Q3 		$28.5K Sell
12,251
-3,344
-21% -$6.31K ﹤0.01% 1124
2025
Q2 		$19.6K Buy
15,595
+2,533
+19% +$2.49K ﹤0.01% 1092
2025
Q1 		$11.9K Buy
13,062
+935
+8% +$1.22K ﹤0.01% 968
2024
Q4 		$19.3K Buy
+12,127
New +$24.4K ﹤0.01% 769

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Focus Partners Advisor Solutions's CRBU Position: Q1 2026 in Review

Focus Partners Advisor Solutions sold out of Caribou Biosciences (CRBU) in Q1 2026, closing a stake of 12,216 shares — an estimated $19.4K sold.

Focus Partners Advisor Solutions first reported a position in CRBU in Q4 2024 and held it in 5 quarters. The position peaked at $28.5K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Focus Partners Advisor Solutions reported no remaining Caribou Biosciences position as of Q1 2026 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 12,216 Caribou Biosciences shares in Q1 2026, an estimated $19.4K.
  • Focus Partners Advisor Solutions first reported a position in Caribou Biosciences in Q4 2024 and held it in 5 quarters.
  • Focus Partners Advisor Solutions's Caribou Biosciences position peaked at $28.5K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.